![[BioSnap] GSK Korea expands indications for RSV vaccine ‘Arexvi’](https://img.yna.co.kr/etc/inner/KR/2026/07/02/AKR20260702155400017_01_i_P2.jpg)
[BioSnap] GSK Korea expands indications for RSV vaccine ‘Arexvi’
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Park Sang-hyun = GSK Korea announced that the number of people eligible for vaccination with the respiratory syncytial virus (RSV) vaccine 'Arexvi' has been expanded.
📰 Related Articles
Yonhap
Dollar-won decline widens overnight due to lower-than-expected U.S. employment... Closed at 1,540.00 won
Yonhap
[World Cup] What did Son Heung-min’s best friend specially pack? Messi also 'laughed loudly'
Yonhap
[Venesu earthquake] We survived for 8 days due to the ruins of the building… Dramatic rescue of a security guard in his 40s (comprehensive)
Yonhap
Canada-led push to establish ‘Global Defense Bank’… “Possibility of joining Korea”
Yonhap